Sang Hoon Lee
Metro Region: South Korea
Member Since: 2022
Prior to ABL, Dr. Lee co-founded PharmAbcine where he oversaw all research and development for antibody therapeutic projects. Before that, he was responsible for drug discovery and preclinical development as the Head of the Bio Division at Hanwha Chemical.
Dr. Lee also brings years of experience from global biopharmaceutical companies, including Chiron(Novartis), AstraZeneca, Genentech, and Exelixis, where he gained cross-functional knowledge in drug discovery, preclinical and clinical development of therapeutic antibodies.
Dr. Lee received his Ph.D. in Molecular, Cellular, and Developmental Biology at The Ohio State University and obtained his postdoctoral fellowship at Harvard Medical School and Stanford. He earned his M.S. in Developmental Biology and B.S. in Biology Education from Seoul National University.